Men living with HIV represent an important but often overlooked group in the aesthetic medicine conversation. The facial changes associated with HIV — including lipoatrophy (loss of facial fat), accelerated skin aging, and characteristic changes from certain antiretroviral medications — have significant aesthetic impact, and Botox and facial fillers are used by HIV-positive men who want to address these effects. With modern antiretroviral therapy, HIV-positive men have near-normal life expectancies and many are actively managing their appearance and wellbeing. This guide covers what's safe, what's effective, and what HIV-positive men should discuss with their providers.
Why HIV Accelerates Facial Aging
HIV affects facial aging through several mechanisms. Chronic immune activation — the low-grade inflammation that persists even in well-controlled HIV — accelerates collagen degradation and elastin breakdown, speeding up the general aging process. HIV-associated lipoatrophy — the loss of subcutaneous fat in characteristic distribution including the face, cheeks, temples, and orbital areas — was far more prevalent with older NRTI medications but still occurs at lower rates with modern regimens. Metabolic changes from HIV and ART can contribute to fat redistribution. Many HIV-positive men also have histories of significant psychological stress, social isolation, and periods of illness that have additional aging effects.
Is Botox Safe for HIV-Positive Men?
Ready to find a provider near you?
Search by Zip Code →Yes, with appropriate precautions. Botox is safe for immunocompromised patients in the context of well-controlled HIV on ART with adequate CD4 counts — typically above 200 cells per microliter. The primary safety considerations are infection risk and immune response. Injectable treatments carry a small infection risk from skin puncture, which is slightly elevated in immunocompromised individuals, but the infection risk of Botox injections specifically is extremely low given the needle gauge, injection depth, and treatment site sterility. Men with very low CD4 counts below 100 or active opportunistic infections should postpone elective procedures until their immune status improves. Always disclose your HIV status and current treatment to your injector.
On disclosure: You are not legally required to disclose HIV status for cosmetic procedures in most US states, but it is medically important. Your injector needs to know your immune status to make appropriate decisions about treatment timing, post-care, and infection risk management. HIV disclosure to medical providers is protected by HIPAA and does not affect your right to receive cosmetic treatment. Providers who decline to treat HIV-positive patients are operating outside current medical standards.
Facial Lipoatrophy: Where Fillers Come In
For men with HIV-associated facial lipoatrophy, Botox addresses surface-level expression lines but doesn't address the underlying volume loss. The standard of care for HIV lipoatrophy is facial filler — specifically, Sculptra (poly-L-lactic acid) was FDA-approved specifically for HIV-associated facial lipoatrophy in 2004, making it one of the few aesthetic fillers with a specific medical indication for this population. Radiesse (calcium hydroxylapatite) is also widely used. Hyaluronic acid fillers can be used for specific areas but typically aren't sufficient for large-volume lipoatrophy. Men who have experienced significant lipoatrophy should consult a provider experienced with HIV lipoatrophy specifically.
Ready to find a provider near you?
Search by Zip Code →Botox Applications Relevant to HIV-Positive Men
Beyond cosmetic Botox for expression lines — which are safe and appropriate for HIV-positive men — specific medical applications are relevant. Hyperhidrosis (excessive sweating) occurs at elevated rates in HIV, possibly related to autonomic nervous system involvement and medication side effects. Botox for hyperhidrosis is FDA-approved and highly effective. Some men with HIV develop involuntary facial movements or spasms that respond to Botox. The full range of Botox applications applies to HIV-positive men with the same considerations as any patient, adjusted for immune status.
Medication Interactions to Know
Most ART medications don't have documented interactions with Botox. Botox is locally metabolized and not significantly affected by systemic drug metabolism. If you take any antibiotics in your HIV management regimen, inform your injector — aminoglycoside antibiotics have a theoretical interaction with Botox's neuromuscular blocking mechanism, though these are rarely used in outpatient HIV management. Disclose your full medication list at every appointment. Find a provider at /find-botox-near-me and ask explicitly about their experience with HIV-positive patients.
Ready to find a provider near you?
Search by Zip Code →Finding the Right Provider
The ideal provider for HIV-positive men has experience treating immunocompromised patients, ideally with specific experience in HIV aesthetics. Academic medical centers and larger urban areas — particularly cities with active LGBTQ+ health communities — often have providers with this experience. Some practices actively specialize in HIV aesthetics and understand both the technical requirements and patient experience aspects that matter. Ask directly: 'Do you have experience treating HIV-positive patients?' and 'Are you familiar with HIV-associated lipoatrophy treatment?' Their answers will indicate their level of expertise.